
1. Bull Exp Biol Med. 2021 Nov;172(1):49-52. doi: 10.1007/s10517-021-05329-7. Epub
2021 Nov 17.

Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) 
Biology.

Chepurnov AA(1), Kazachinskaya EI(2), Kazachkova EA(2), Sharshov KA(2), Kononova 
YV(2), Shelemba AA(2), Alekseev AY(2), Gulyeva MA(2), Voevoda MI(2), Shestopalov 
AM(2).

Author information: 
(1)Federal Research Center of Fundamental and Translational Medicine,
Novosibirsk, Russia. alexa.che.purnov@gmail.com.
(2)Federal Research Center of Fundamental and Translational Medicine,
Novosibirsk, Russia.

Different methods for producing bulk quantities of concentrated and purified
SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology
were tested.

Â© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

DOI: 10.1007/s10517-021-05329-7 
PMCID: PMC8596366
PMID: 34787781 

